86 related articles for article (PubMed ID: 23313782)
1. Normal colon tissue and colon carcinoma show no difference in heparanase promoter methylation.
Peerless Y; Simon E; Sabo E; Ben-Izhak O; Hershkovitz D
Exp Mol Pathol; 2013 Apr; 94(2):309-13. PubMed ID: 23313782
[TBL] [Abstract][Full Text] [Related]
2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
3. Expression of heparanase in normal, dysplastic, and neoplastic human colonic mucosa and stroma. Evidence for its role in colonic tumorigenesis.
Friedmann Y; Vlodavsky I; Aingorn H; Aviv A; Peretz T; Pecker I; Pappo O
Am J Pathol; 2000 Oct; 157(4):1167-75. PubMed ID: 11021821
[TBL] [Abstract][Full Text] [Related]
4. Promoter CpG hypomethylation and transcription factor EGR1 hyperactivate heparanase expression in bladder cancer.
Ogishima T; Shiina H; Breault JE; Terashima M; Honda S; Enokida H; Urakami S; Tokizane T; Kawakami T; Ribeiro-Filho LA; Fujime M; Kane CJ; Carroll PR; Igawa M; Dahiya R
Oncogene; 2005 Oct; 24(45):6765-72. PubMed ID: 16007175
[TBL] [Abstract][Full Text] [Related]
5. Role of promoter methylation in regulation of the mammalian heparanase gene.
Shteper PJ; Zcharia E; Ashhab Y; Peretz T; Vlodavsky I; Ben-Yehuda D
Oncogene; 2003 Oct; 22(49):7737-49. PubMed ID: 14586400
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells.
Cho CY; Wang JH; Chang HC; Chang CK; Hung WC
J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689
[TBL] [Abstract][Full Text] [Related]
7. Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin M; Cohen I; Zcharia E; Orgel A; Guatta-Rangini Z; Peretz T; Vlodavsky I; Kleinman HK
Cancer Res; 2003 Dec; 63(24):8821-6. PubMed ID: 14695198
[TBL] [Abstract][Full Text] [Related]
8. Methylation status of T-lymphoma invasion and metastasis 1 promoter and its overexpression in colorectal cancer.
Jin H; Li T; Ding Y; Deng Y; Zhang W; Yang H; Zhou J; Liu C; Lin J; Ding Y
Hum Pathol; 2011 Apr; 42(4):541-51. PubMed ID: 21237486
[TBL] [Abstract][Full Text] [Related]
9. Heparanase expression correlates with malignant potential in human colon cancer.
Nobuhisa T; Naomoto Y; Ohkawa T; Takaoka M; Ono R; Murata T; Gunduz M; Shirakawa Y; Yamatsuji T; Haisa M; Matsuoka J; Tsujigiwa H; Nagatsuka H; Nakajima M; Tanaka N
J Cancer Res Clin Oncol; 2005 Apr; 131(4):229-37. PubMed ID: 15625607
[TBL] [Abstract][Full Text] [Related]
10. Co-expression of CD44v3 and heparanase is correlated with metastasis of human colon cancer.
Kuniyasu H; Chihara Y; Kubozoe T; Takahashi T
Int J Mol Med; 2002 Sep; 10(3):333-7. PubMed ID: 12165810
[TBL] [Abstract][Full Text] [Related]
11. RASSF1A promoter methylation and expression analysis in normal and neoplastic kidney indicates a role in early tumorigenesis.
Peters I; Rehmet K; Wilke N; Kuczyk MA; Hennenlotter J; Eilers T; Machtens S; Jonas U; Serth J
Mol Cancer; 2007 Jul; 6():49. PubMed ID: 17634119
[TBL] [Abstract][Full Text] [Related]
12. [Role of eukaryotic initiation factor-4E (eIF-4E) in regulation of expression of NF-kappaB and its subsequent influence on transcription and activity of heparanase in human colon adenocarcinoma cell line].
Yang YJ; Zhang YL; Wang JD; Lai ZS; Wang QY; Cui HH
Ai Zheng; 2003 Oct; 22(10):1023-9. PubMed ID: 14558943
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation of heparanase promoter influences its expression and associated with the progression of human breast cancer.
Jiao F; Bai SY; Ma Y; Yan ZH; Yue Z; Yu Y; Wang X; Wang J
PLoS One; 2014; 9(3):e92190. PubMed ID: 24632672
[TBL] [Abstract][Full Text] [Related]
14. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
15. Heparanase: a key enzyme in invasion and metastasis of gastric carcinoma.
Tang W; Nakamura Y; Tsujimoto M; Sato M; Wang X; Kurozumi K; Nakahara M; Nakao K; Nakamura M; Mori I; Kakudo K
Mod Pathol; 2002 Jun; 15(6):593-8. PubMed ID: 12065771
[TBL] [Abstract][Full Text] [Related]
16. Mammalian heparanase as mediator of tumor metastasis and angiogenesis.
Vlodavsky I; Elkin M; Pappo O; Aingorn H; Atzmon R; Ishai-Michaeli R; Aviv A; Pecker I; Friedmann Y
Isr Med Assoc J; 2000 Jul; 2 Suppl():37-45. PubMed ID: 10909416
[TBL] [Abstract][Full Text] [Related]
17. Small RNAs targeting transcription start site induce heparanase silencing through interference with transcription initiation in human cancer cells.
Jiang G; Zheng L; Pu J; Mei H; Zhao J; Huang K; Zeng F; Tong Q
PLoS One; 2012; 7(2):e31379. PubMed ID: 22363633
[TBL] [Abstract][Full Text] [Related]
18. Spatial and temporal heparanase expression in colon mucosa throughout the adenoma-carcinoma sequence.
Doviner V; Maly B; Kaplan V; Gingis-Velitski S; Ilan N; Vlodavsky I; Sherman Y
Mod Pathol; 2006 Jun; 19(6):878-88. PubMed ID: 16607375
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of MTUS1 in human colon tumors.
Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S
Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880
[TBL] [Abstract][Full Text] [Related]
20. Reduced hGC-1 protein expression is associated with malignant progression of colon carcinoma.
Liu W; Liu Y; Zhu J; Wright E; Ding I; Rodgers GP
Clin Cancer Res; 2008 Feb; 14(4):1041-9. PubMed ID: 18281536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
